Haven’t seen much if any talk on this group on WSO. From what I’ve heard it’s sweatier than other BB coverage groups as there’s less product group support.
Anyone know about this group, in terms of exits, culture, deal flow etc?
| +147 | AI Creating More Work | 44 | 1d |
| +143 | Senior Banker's Guide to IB Recruiting / Group Placement (with a Healthcare Bent) | 18 | 13h |
| +141 | Shit PWP Culture | 88 | 18h |
| +117 | Is pay at BofA really that bad? | 58 | 1d |
| +81 | Day at Macquarie | 8 | 4h |
| +44 | Is the life of a VP at a 'top-bank' really good? | 15 | 2d |
| +42 | How bad did I mess up | 9 | 2h |
| +29 | Law school instead of MBA for RX Banking | 5 | 2d |
| +29 | No BB RO 2026 | 10 | 1d |
| +27 | Misrepresented Houston IB | 14 | 1m |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump
following
Following
del
Also curious
No Morgan Stanley HC bankers on this forum?
Seems not - seems to place well exit-wise, although I only have n=1, MS HC -> Blackstone Life Sciences
I know they worked on Merck-Prometheus. The one guy I talked to there was a nice guy, but other than that I don’t know much. CVP or JPM is probably better deal wise but honestly you can’t go wrong with MS.
Agreed- think they also worked on Amgen-Horizon and are on some PE type deals with royalty Pharma and BXLS
Amgen-Horizon was the SF group I believe. I know SF has Amgen on account.
.
Thank you! This is definitely the most helpful piece of insight on this forum, am really learning more about this group so I thank you!
I know you covered a lot, but if I had to just add another follow up- did you notice anyone exiting into Biotech investing (HF or Royalty PE type)?
Biotech is arguably the strongest part of the franchise imo; quite a few of the best biotech IPOs / FOs recently have been done by this group, and very strong in biopharma M&A as well. See rainmakers like Clint Gartin (over a fucking trillion in M&A volume, total baller whose son was opposite him at Citi on Bristol) and Joe Modisett.
Tbh the biopharma subvertical within MS HC kinda does their own thing and has their choice of analysts because it's so dominant, but pretty much anyone that even remotely wants to do biotech gets some of those staffings. Just pray you don't get assigned the biotech update internal staffing lol
Sorry, to actually answer your question-- I did a few biotech deals and have practically gotten harassed by some of the major biotech funds to interview. If you're interested in Sixth Street, RA Capital, Deerefield etc. you will have a very very easy time compared to p much any other coverage group on the street. The story makes total sense, the work is transferrable, and there's a very strong pipeline historically. Like I said-- focus on getting into the group first, because it can be pretty competitive
To be specific, would you say this covers just MS HC NY or is the SF group at the same level as well? Thanks
How them bonus numbers tho LMAO. Brokie out here coping
attractive analysts, mainly girls
.
It is sweatier, but Healthcare is a sweaty group across banks. Having worked at two IBs, I wouldn't say that HC at MS is particularly worse than it is anywhere else. Generally the internal BS items are easier at MS than other places (credit committees, equity committees, etc.) so most of your time is spent on client-facing work, which is definitely a plus
Culture-wise the group is pretty solid - no overwhelmingly difficult personalities and everyone is generally friendly
Disagree. Group has toxic culture. Vindictive, conniving seniors. Highest turnover at MS.
Avoid at all costs if possible.
Quasi sunt amet quaerat officiis dolorum nemo laboriosam. Tenetur laboriosam ea deleniti reiciendis aut. Fuga omnis tenetur odit et rem et. Odit nihil tempora accusamus repellendus.
Aperiam provident deserunt blanditiis itaque maxime. Ad sint quasi optio aut enim nulla.
Et qui doloremque et cumque sed inventore sunt sint. Est laborum sit nulla qui nisi nisi. Aut sequi vel distinctio odio perspiciatis esse. Quis quidem ut sed aut voluptatem quisquam dolorem.
In ab dolor inventore voluptas qui et. Nesciunt asperiores repellat numquam eaque nihil. Officiis atque est sed vel impedit iste placeat. Iure porro nemo et voluptatibus. Eius necessitatibus qui doloribus commodi adipisci velit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Tempora atque eveniet odio earum cupiditate distinctio. Nihil perspiciatis tenetur et numquam quia velit architecto. Suscipit impedit nihil non aliquam. Quaerat quidem eos rerum. Vero quis excepturi consequuntur ut ullam totam impedit. Voluptas cumque qui autem ratione quia omnis eius.
Enim aperiam atque alias qui occaecati eligendi et dolorem. Ut quis sint quia ea est molestiae vitae est. Tempora facilis veniam minima officiis. Accusamus quis ab dolorem et et sequi. Dolorem dolor natus possimus dolorum ipsum. Ad dolores saepe aut et eos placeat. Nihil expedita consequatur perferendis quisquam exercitationem.